NCAM1 and cancer: CD56+ natural killer (NK) cells can express Fc receptors and mediate antibody-dependent cell-mediated cytotoxicity (ADCC) by binding to the Fc part of cancer cells Ig G, thereby inducing activation signals and killing target cells [30, 31].